PD-L1 is overexpressed in cancer cells, which enhances their tumorigenic potential intrinsically (immune-independent) [1,2,3,4] or through immune evasion of immune surveillance via PD-1-mediated T-cell inactivation [5,6,7,8]. Here, CD274 is linked to cancer.